Bosch Pharma Solid Symposium 2014: International conference on solid pharmaceuticals

Das neue Pharma-Labor vereint die Pharmaportfolio-Schwerpunkte der deutschen Bosch Packaging Technology Standorte Schopfheim und Waiblingen sowie des britischen Knowsley in einem Kompetenzzentrum. / The new pharma Iabaratory combines the pharmaceutical portfolio focus areas oftheGerman Bosch Packaging Technology sites Schopfheim and Waiblingen with the British site Knowsley in one center of competence.

Die Kapselfüllmaschine GKF 702 ist besonders flexible und eignet sich für sämtliche gebräuchlichen Fülltechnologien. / The extremely flexible GKF 702 capsule filling machine is suitable for all standard filling techniques

Solidlab 2: gemeinsame Entwicklung von Hüttlin und Manesty: Die kompakte und modulare Anlage vereint mehrere Prozessschritte auf kleinstem Raum: Trocknen, Granulieren und Coaten in der Wirbelschicht sowie Tablettenbeschichten im Coater. / Solidlab 2: joint development by Hüttlin and Manesty: The compact and modular machine combines several process steps in a small space: drying, granulating and coating in the fluid bed, as weil as tablet coating in the coater.

Internationale Tagung in neuem Pharma-Labor: Bosch Packaging Technology feierte im Rahmen eines internationalen Symposiums zu festen Pharmazeutika die Neueröffnung des Schopfheimer Pharma-Labors. / International conference at new pharma laboratory: Bosch Packaging Technology celebrated the opening of the pharma Iabaratory in Schopfheim during an international conference on solid pharmaceuticals.

- Two-day industry meeting with around 100 participants
- New center of competence for development and process optimization
- Expert lectures and discussions from research and industry

On February 19 and 20, 2014, Bosch Packaging Technology, a leading supplier of process and packaging technology, held its Pharma Solid Symposium in Schopfheim, Germany, which gave occasion for the opening of the pharmaceutical laboratory. The international conference offered industry experts an opportunity to comprehensively inform themselves about current trends and developments in the manufacturing and processing of solid dosage forms. “We can look back on two exciting and successful days, during which top-class speakers provided our international guests with up-to-date industry knowledge. In addition, our diversified program provided sufficient room for personal exchange, as well as the chance to get to know our site in Schopfheim better,” explained general manager Martin Gross.

Inauguration of new laboratory

Martin Gross and his guests inaugurated the new laboratory during a tour of the premises on the first day of the event. The new facility combines the pharmaceutical portfolio focus areas of the German Bosch Packaging Technology sites Schopfheim and Waiblingen with the British site Knowsley in one center of competence. “We have consistently expanded our laboratory over the past years. Now we offer our customers the appropriate services and machines for all stages – from development to production of their solid pharmaceuticals,” Martin Gross explained. Ten machines from the Hüttlin and Manesty product portfolio, as well as from the site in Waiblingen, are available for tests in an area of more than 300 square meters. The wide range of equipment covers all process steps in the production of solid dosage forms: from mixing, drying, granulating and coating of fine particles and pellets to pressing and coating of tablets and filling of capsules. 

Bosch Packaging Technology’s pharmaceutical laboratory concept enables customers to test machines and formulations on-site. Bosch experts are on hand to support them during the entire development process of their pharmaceuticals, right through to the start of production and beyond. Additional laboratories for trials and feasibility studies are being established at different sites around the world. In the recently opened customer center in Waiblingen, experts assist pharmaceutical manufacturers in familiarizing with Bosch capsule filling machines.

Concentrated expert knowledge

The second day of the symposium focused on lectures and a panel discussion. After the welcome address by Ralf Schmied, director of product area Pharma Solid in Waiblingen, representatives of leading pharmaceutical companies and renowned research institutes reported on new procedures and challenges in the production of solid dosage forms. Speakers included delegates of Hoffmann LaRoche, Capsugel and Excella, as well as the Heinrich Heine University of Düsseldorf, the Johannes Gutenberg University of Mainz, and the Ernst Moritz Arndt University of Greifswald. 

The speakers explored a range of new trends and developments in the fields of micro dosing, nanoformulation, biopharmaceuticals and containment. The subsequent panel discussion, moderated by Dr. Martin Opitz, senior market expert from Bosch Packaging Technology, provided the opportunity to debate and reflect the presented topics. “We are very satisfied with the outcome of the Bosch Pharma Solid Symposium 2014,” Dr. Martin Opitz emphasized. “The active participation in the discussions showed how exciting it can be to look upon current topics from different perspectives. Once again, our guests also gave us valuable food for thought.”